Evidence map›Paper›PMID 41794958›Full record

ArticleNpj mental health research2026

Navigating the complexity of AI adoption in psychotherapy by identifying key facilitators and barriers.

Julia Cecil, Insa Schaffernak, Danae Evangelou, Eva Lermer, Susanne Gaube, Anne-Kathrin Kleine

Abstract read
In one paragraph

Article in Npj mental health research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Julia CecilDepartment of Psychology, LMU Center for Leadership and People Management, LMU Munich, Munich, Germany. julia.cecil@psy.lmu.de.
Insa SchaffernakDepartment of Business Psychology, Technical University of Applied Sciences Augsburg, Augsburg, Germany.
Danae EvangelouDepartment of Psychology, LMU Center for Leadership and People Management, LMU Munich, Munich, Germany.
Eva LermerDepartment of Psychology, LMU Center for Leadership and People Management, LMU Munich, Munich, Germany.
Susanne GaubeUCL Global Business School for Health, University College London, London, UK.
Anne-Kathrin KleineDepartment of Psychology, LMU Center for Leadership and People Management, LMU Munich, Munich, Germany.

Funding

Volkswagen Foundation 98525
6 · The paper itself

Abstract

Artificial intelligence (AI) technologies in mental healthcare offer promising opportunities to reduce therapists' burden and enhance healthcare delivery, yet adoption remains challenging. This study identified key facilitators and barriers to AI adoption in mental healthcare, precisely psychotherapy, by conducting six online focus groups with patients and therapists, using a semi-structured guide based on the NASSS (Nonadoption, Abandonment, Scale-up, Spread, and Sustainability) framework. Data from N = 32 participants were analyzed using a combined deductive and inductive thematic analysis. Across the seven NASSS domains, 36 categories emerged. Sixteen categories were identified as factors facilitating adoption, including useful technology elements, the customization to user needs, and cost coverage. Eleven categories were perceived as barriers to adoption, encompassing the lack of human contact, resource constraints, and AI dependency. Further nine, such as therapeutic approach and institutional differences, acted as both facilitators and barriers depending on the context. Our findings highlight the complexity of AI adoption in mental healthcare and emphasize the importance of addressing barriers early in the development of AI technologies.

Identifiers

PMID41794958
PMCPMC12967751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.